Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Erlotinib | 19.9526 | uM | 9 | 312.50 | 200.50 | 372.00 | 341.75 | 1.0885 | 1.2331 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 9 | 312.50 | 200.50 | 255.00 | 341.75 | 0.7462 | 0.3669 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 9 | 312.50 | 200.50 | 400.00 | 341.75 | 1.1704 | 1.4540 |
| SK-BR-3 | 0 | uM | 9 | 312.50 | 200.50 | 460.00 | 341.75 | 1.3460 | 1.9429 | |
| SK-BR-3 | 17-AAG | 0.1 | uM | 9 | 312.50 | 200.50 | 183.00 | 341.75 | 0.5355 | -0.1119 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 9 | 312.50 | 200.50 | 396.00 | 341.75 | 1.1587 | 1.4221 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 9 | 312.50 | 200.50 | 191.00 | 341.75 | 0.5589 | -0.0611 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 9 | 312.50 | 200.50 | 395.00 | 341.75 | 1.1558 | 1.4142 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 9 | 312.50 | 200.50 | 257.00 | 341.75 | 0.7520 | 0.3808 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 9 | 312.50 | 200.50 | 472.00 | 341.75 | 1.3811 | 2.0430 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 9 | 312.50 | 200.50 | 307.00 | 341.75 | 0.8983 | 0.7398 |
| SK-BR-3 | Erlotinib | 1 | uM | 9 | 312.50 | 200.50 | 271.00 | 341.75 | 0.7930 | 0.4794 |
| SK-BR-3 | 17-AAG | 0.000302 | uM | 9 | 312.50 | 200.50 | 327.00 | 341.75 | 0.9568 | 0.8885 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 9 | 312.50 | 200.50 | 163.00 | 341.75 | 0.4770 | -0.2360 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 9 | 312.50 | 200.50 | 131.00 | 341.75 | 0.3833 | -0.4249 |
| SK-BR-3 | 0 | uM | 9 | 312.50 | 200.50 | 196.00 | 341.75 | 0.5735 | -0.0291 | |
| SK-BR-3 | 0 | uM | 9 | 312.50 | 200.50 | 295.00 | 341.75 | 0.8632 | 0.6519 | |
| SK-BR-3 | Linsitinib | 1 | uM | 9 | 312.50 | 200.50 | 251.00 | 341.75 | 0.7345 | 0.3391 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 9 | 312.50 | 200.50 | 395.00 | 341.75 | 1.1558 | 1.4142 |
| SK-BR-3 | 0 | uM | 9 | 312.50 | 200.50 | 360.00 | 341.75 | 1.0534 | 1.1399 | |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 9 | 312.50 | 200.50 | 217.00 | 341.75 | 0.6350 | 0.1083 |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 9 | 312.50 | 200.50 | 371.00 | 341.75 | 1.0856 | 1.2253 |
| SK-BR-3 | Erlotinib | 10 | uM | 9 | 312.50 | 200.50 | 206.00 | 341.75 | 0.6028 | 0.0358 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 9 | 312.50 | 200.50 | 260.00 | 341.75 | 0.7608 | 0.4018 |
| SK-BR-3 | 17-AAG | 0.0031623 | uM | 9 | 312.50 | 200.50 | 252.00 | 341.75 | 0.7374 | 0.3460 |